G protein-coupled receptor systems involved in cell growth and oncogenesis

Endocrine Reviews

Volumn 16, Issue 3, 1995, Pages 259-270

  Dhanasekaran, N ^a   Heasley, Lynn E ^b   Johnson, Gary L ^c  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; CARCINOGENESIS; CELL GROWTH; CELL HYPERPLASIA; ENZYME ACTIVITY; GENE ACTIVATION; GENE MUTATION; LUNG SMALL CELL CANCER; MALIGNANT TRANSFORMATION; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; STOMACH MUCOSA;

AMINO ACID SEQUENCE; ANIMAL; CELL DIVISION; GENE EXPRESSION REGULATION, NEOPLASTIC; GTP-BINDING PROTEINS; HUMAN; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; ONCOGENES; RECEPTORS, CELL SURFACE; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0029011084     PISSN: 0163769X     EISSN: 0163769X     Source Type: Journal    
DOI: 10.1210/edrv-16-3-259     Document Type: Article

References (123)

1. Hepler JR, Gilman AG 1992 G proteins. Trends Biochem Sci 17: 383-387
2. Clapham D, Neer EJ 1993 New roles: G protein /By-dimers in transmembrane signalling. Nature 365:403-406
3. Clapham DE 1994 Mutations in G protein-linked receptors: novel insights on disease. Cell 75:1237-1239
4. Lefkowitz RJ 1993 Turned on to ill effect. Nature 365:603-604
5. Bishop JM 1991 Molecular themes in oncogenesis. Cell 64:235-248
6. Hunter T 1991 Cooperation between oncogenes. Cell 64:249-270
7. Cantley LC, Auger KR, Carpenter C, Duckworth B, Graziani A, Kapellar R, Soltoff S, 1991 Oncogenes and signal transduction. Cell 64:281-302
8. Johnson GL, Dhanasekaran N, Gupta SK, Lowndes JM, Vaillan-Court RR, Ruoho AE 1991 Genetic and structural analysis of G protein a subunit regulatory domains. J Cell Biochem 47:136-146
9. Gupta SK, Gallego C, Johnson GL 1992 Mitogenic pathways regulated by G protein oncogenes. Mol Biol Cell 3:123-128
10. McCormick F 1989 ras oncogenes. In: Weinberg RA (ed) Oncogenes and the Molecular Origins of Cancer. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp 125-145
11. Tabin C, Bradley S, Bargmann C, Weinberg R, Papageorge A, Scolnick E, Dhar R, Lowy D, Chang E 1982 Mechanism of activation of a human oncogene. Nature 300:143-148
12. Taparowsky E, Suard Y, Fassano D, Simizer K, Goldfarb M, Wigler M 1982 Activation of T24 bladder carcinoma transforming gene is linked to a single amino acid change. Nature 300:762-765
13. Reddy EP, Reynolds RK, Santos E, Barbacid M 1982 A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature 300:149-152
14. s and stimulate adenylyl cyclase in human pituitary tumors. Nature 340: 692-696
15. Bourne HR, Sanders DA, McCormick F 1991 The GTPase superfamily: conserved structure and molecular mechanisms. Nature 349:117-127
16. sa. J Biol Chem 264:15475-15482
17. Freissmuth M, Gilman AG 1989 Mutations of Ga designed to alter the reacitivity of the protein with bacterial toxins. J Biol Chem 264:21907-21914
18. Masters SB, Miller TR, Chi M-H, Cheng FH, Biederman B, Lopez WG, Bourne HR 1989 Mutations in the GTP-binding site of Gsa alter stimulation of adenylyl cyclase. J Biol Chem 264:15467-15474
19. Boguski MS, McCormick F 1993 Proteins regulating Ras and its relatives. Nature 366:643-654
20. Lyons J, Landis CA, Harsh G, Vallar L, Grunewald K, Feichtinger H, Suk Q-Y, Clark OH, Kawasaki E, Bourne HR 1990 Two G protein oncogenes in human endocrine tumors. Science 249:655-659
21. Saurez HG, du Villard JA, Caillou B, Schumberger M, Parmentier C, Monier R 1991 gsp Mutations in human thyroid tumors. Oncogene 6:677-679
22. s protein a subunit-gsp oncogene is found in human pituitary tumors. Oncogene 5:1059-1061
23. O’Sullivan C, Barton CM, Staddon SL, Brown CL, Lemoine NR 1991 Activating point mutations of the gsp oncogene in human thyroid adenomas. Mol Carcinog 4:345-349
24. s and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature 330:566-568
25. Dumont JE, Jauniaux JC, Roger PP 1989 The cyclic AMP-mediated stimulation of cell proliferation. Trends Biochem Sci 14:67-71
26. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM 1991 Activating mutations of the stimulatory G protein in the McCune-Albright Syndrome. N Engl J Med 325:1688-1695
27. 12 gene product. Mol Cell Biol 13:762-768
28. Cho-Chung YS, Clair T, Tagliaferri P, Ally S, Katsoros D, Tortora G, Nechers L, Avery TL, Crabtree GW, Robins RK 1989 Site-selective cyclic AMP analogs as new biological tools in growth control, differentiation, and proto-oncogene regulation. Cancer Invest 7:161-177
29. Rozengurt E 1986 Early signals in the mitogenic response. Science 234:161-166
30. Zachary I, Masters SB, Bourne HR 1990 Increased mitogenic responsiveness of Swiss 3T3 cells expressing constitutively active Gsa. Biochem Biophys Res Commun 168:1184-1193
31. t chimera that constitutively activates cAMP synthesis. J Biol Chem 264:5687-5693
32. s in β-cells of transgenic mice causes counterregulation of the increased adenosine 3’, 5’-monophosphate and insulin secretion. Endocrinology 134:42-47
33. s. Science 263:1278-1281
34. Russell M, Winitz S, Johnson GL 1994 Acetylcholine muscarinic ml receptor regulation of cyclic AMP synthesis controls growth factor stimulation of Raf activity. Mol Cell Biol 14:2343-2351
35. Cook SJ, McCormick F 1993 Inhibition by cAMP of Ras-dependent activation of Ras. Science 262:1069-1072
36. Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ, Sturgill TW 1993 Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3’, 5’-monophosphates. Science 262:1065-1069
37. i2 induces neoplastic transformation of Rat-1 cells. Proc Natl Acad Sci USA 88:7031-7035
38. Gupta SK, Gallego C, Lowndes JM, Pleiman CM, Sable C, Eisfelder BJ, Johnson GL 1992 Analysis of the fibroblast transformation potential of GTPase-deficient gip2 oncogene. Mol Cell Biol 12:190-197
39. i2 oncogene gip2 inhibits adenylyl cyclase and attenuates receptor-stimulated phospholipase A2 activity. J Biol Chem 266:14193-14197
40. ras proteins bind to the amino-terminal regulatory domains of c-Raf-1. Nature 364:308-313
41. Kyriakis JM, App H, Zhang X-F, Banerjie P, Brautigan DL, Rapp UR, Avruch J 1992 Raf-1 activates MAP kinase-kinase. Nature 358:417-421
42. Feig LA, Cooper GM 1988 Inhibition of NIH3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol Cell Biol 8:3235-3243
43. Gupta SK, Gallego C, Johnson GL, Heasley LE 1992 MAP kinase is constitutively activated in gip2 and src transformed Rat la fibroblasts. J Biol Chem 267:7987-7990
44. Gallego C, Gupta SK, Heasley LE, Qian N-X, Johnson GL 1992 MAP kinase activation resulting from selective oncogene expression in NIH3T3 and Rat la cells. Proc Natl Acad Sci USA 89:7355-7359
45. Samuels ML, Weber MJ, Bishop JM, McMahon M 1993 Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human Raf-1 protein kinase. Mol Cell Biol 13:6241-6252
46. q subfamily of guanine nucleotide-binding regulatory protein a subunits attenuate activation of phosphatidylinositol 4, 5-bisphosphate hydrolysis by hormones. J Biol Chem 266:20519-20524
47. u proteins in transfected Cos-7 cells. J Biol Chem 267:1811-1817
48. Qian N-X, Winitz S, Johnson GL 1993 Epitope-tapped Gaq polypeptides: Expression of GTPase-deficient Gaq persistently stimulates PI-phospholipase C but not MAP kinase activity regulated by the muscarinic Ml receptor. Proc Natl Acad Sci USA 90:4077-4081
49. Kalinec G, Nagaradi AJ, Hermouet S, Xu N, Gutkind JS 1992 Mutated a subunit of the Gq protein induces malignant transformation in NIH3T3 cells. Mol Cell Biol 12:4687-4693
50. DeVivo M, Chen J, Codina J, Iyengar R 1992 Enhanced phospholipase C stimulation and transformation in NIH3T3 cells expressing Q209LGq-a-subunits. J Biol Chem 267:18263-18266
51. 16 inhibits Swiss 3T3 cell growth. J Biol Chem 269:17417-17423
52. Julius D, Livelli TJ, Jessell TM, Axel R 1989 Ectopic expression of the serotonin lc receptor and the triggering of malignant transformation. Nature 244:1057-1062
53. Gutkind JS, Novotny EA, Brown MR, Robbins KC 1991 Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes. Proc Natl Acad Sci USA 88:4703-4707
54. Stephens EV, Kalinec G, Brann MR, Gutkind JS 1993 Transforming G protein-coupled receptors transduce potent mitogenic signals in NIH3T3 cells independent on cAMP inhibition or conventional protein kinase C. Oncogene 8:19-26
55. 1B-adrenergic receptor enhances mitogenesis and tumorigenicity. Proc Natl Acad Sci USA 88:11354-11358
56. Smith MR, Liu Y-L, Kim H, Rhee SG, Fung H-F 1990 Inhibition of serum and Ras-stimulated DNA synthesis by antibodies to phospholipase C. Science 247:1074-1077
57. 12 potentiates the eicosanoid pathway and is highly mitogenic in NIH3T3 cells. Proc Natl Acad Sci USA 90:6741-6745
58. 12. FEBS Lett 3:319-322
59. 13 induces Egr-1, c-fos, and transformation in NIH3T3. Oncogene 9:2425-2429
60. Herschmann HR 1991 Primary response genes induced by growth factors and tumor promoters. Annu Rev Biochem 60:281-319
61. Parma J, Duprey L, Van Sande J, Cochaux P, Gervy C, Mochel J, Dumont J, Vassart G 1993 Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365:649-651
62. Shenker A, Lane L, Kosugi S, Merendino Jr JJ, Minegiski T, Cutler Jr GB 1993 A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 365:652-654
63. Crespo P, Xu N, Simons WF, Gutkind JS 1994 Ras-dependent activation of MAP kinase pathway mediated by G-protein βy subunits. Nature 369:418-420
64. Johnson GL, Vaillancourt RR 1994 Sequential protein kinase reactions controlling cell growth and differentiation. Curr Opin Cell Biol 6:230-238
65. Gerard NP, Gerard C 1991 The chemotactic receptor for human C5a anaphylatoxin. Nature 349:614-616
66. Wu D, LaRosa G, Simon ML 1993 G protein-coupled signal transduction pathways for interleukin 8. Science 261:101-103
67. Buhl AM, Avdi N, Worthen GS, Johnson GL 1994 Mapping of the C5a receptor signal transduction network in human neutrophils. Proc Natl Acad Sci USA 91:9190-9194
68. Rollins TE, Siciliano S, Kobayashi S, Cianciarulo DN, Bonilla-Argudo V, Collier K, Springer MS 1991 Purification of the active C5a receptor from human polymorphonuclear leukocytes as a receptor-Gi complex. Proc Natl Acad Sci USA 88:971-975
69. Worthen SG, Avdi N, Buhl AM, Johnson GL 1994 FMLP activates Ras and Raf in human neutrophils: potential role in activation of MAP kinase. J Clin Invest 94:815-823
70. Winitz SM, Russell M, Qian N-X, Dwyer L, Johnson GL 1993 Involvement of Ras and Raf in Gi-coupled acetylcholine muscarinic m2 receptor activation of mitogen-activated protein (MAP) kinase kinase and MAP kinase. J Biol Chem 268:19196-19199
71. Alblas J, Van Corven EJ, Hordijk PL, Milligan G, Moolenar WH Gj-mediated activation of the p21ras-mitogen activated protein kinase pathway by a2-adrenergic receptors expressed in fibroblasts. J Biol Chem 268:22235-22238
72. ras by G protein-coupled receptor agonists in fibroblasts. Proc Natl Acad Sci USA 90:1257-1261
73. Howe LR, Marshall CJ 1993 Lysophosphatidic acid stimulates mitogen-activated protein kinase activation via a G-protein-coupled pathway requiring p21ras and p74 raf-1. J Biol Chem 268: 20717-20720
74. Sorenson GD, Pettengill OS, Brinck-Johnsen T, Cate CC, Maurer LH 1981 Hormone production by cultures of small-cell carcinoma of the lung. Cancer 47:1289-1296
75. Abe K, Kameya T, Yamaguchi K, Kikuchi K, Adachi I, Tanaka M, Kimura S, Kodama T, Shimosato Y, Ishikawa S 1984 Hormone-producing lung cancers: endocrinologic and morphologic studies. In: Becker KL, Gazdar AF (eds) The Endocrine Lung in Health and Disease. Saunders, London, pp 549-595
76. Ibrahim NBN, Briggs JC, Corbishley CM 1984 Extrapulmonary oat cell carcinoma. Cancer 545:1645-1661
77. Levenson RM, Ihde DC, Matthews MJ, Cohen MH, Gazdar AF, Bunn Jr PE, Minna JD 1981 Small cell carcinoma presenting as an extrapulmonary neoplasm: sites of origin and response to chemotherapy. J Natl Cancer Inst 67:607-612
78. Johnson BE, Whang-Peng J, Naylor SL, Zbar B, Brauch H, Lee E, Simmons A, Russel E, Nam MH, Gazdar AF 1989 Retention of chromosome 3 in extrapulmonary small cell cancer shown by molecular and cytogenetic studies. J Natl Cancer Inst 81:1223-1228
79. Mitsudomi T, Viallet J, Mulshine JL, Linnoila I, Minna JD, Gazdar AF 1991 Mutations of ras genes distinguish a subset of nonsmall-cell lung cancer cell lines from small-cell lung cancer cell lines. Oncogene 6:1353-1362
80. Cemy T, Barnes DM, Hasleton P, Barber PV, Healy K, Gullick W, Thatcher N 1986 Expression of epidermal growth factor receptor (EGF-R) in human lung tumours. Br J Cancer 54:265-269.
81. Mabry M, Nakagawa T, Nelkin BD, McDowell E, Gesell M, Eggleston JC, Casero Jr RA, Baylin SB 1988 v-Ha-ras oncogene insertion: a model for tumor progression of human small cell lung cancer. Proc Natl Acad Sci USA 85:6523-6527
82. Mabry M, Nakagawa T, Baylin S, Pettengill O, Sorenson G, Nelkin B 1989 Insertion of the v-Ha-ras oncogene induces differentiation of calcitonin-producing human small cell lung cancer. J Clin Invest 84:194-199
83. Cuttitta F, Carney DN, Mulshine J, Moody TW, Fedorko J, Fischler A, Minna JD 1985 Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 316:823-826
84. 13/14] Bombesin analogues inhibit growth of small cell lung cancer in vitro and in vivo. Cancer Res 51:1798-1802
85. Carney DN, Gazdar AF, Bepler G, Guccion JG, Marangos PJ, Moody TW, Zweig MH, Minna JD 1985 Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res 45:2913-2923
86. Sausville E, Carney D, Battey J 1985 The human vasopressin gene is linked to the oxytocin gene and is selectively expressed in a cultured lung cancer cell line. J Biol Chem 260:10236-10241
87. Moody TW, Carney DN, Korman LY, Gazdar AF, Minna JD 1985 Neurotensin is produced by and secreted from classic small cell lung cancer cells. Life Sci 36:1727-1732
88. Giejer T, Folkesson R, Rehfeld JF, Monstein H-J 1990 Expression of the cholecystokinin gene in a human (small-cell) lung carcinoma cell-line. FEBS Lett 270:30-32
89. North WG 1991 Neuropeptide production by small cell carcinoma: vasopressin and oxytocin as plasma markers of disease. J Clin Endocrinol Metab 73:1316-1320
90. Verbeeck MAE, Elands JPM, de Leij LFMH, Buys CHCM, Carney DN, Bepler G, Roebroeck AJM, Van De Ven WJM, Burbach JPH 1992 Expression of the vasopressin and gastrin-releasing peptide genes in small cell lung carcinoma cell lines. Pathobiology 60:136-142
91. Gross AJ, Steinberg SM, Reilly JG, Bliss Jr DP, Brennan J, Le PT, Simmons A, Phelps R, Mulshine JL, Ihde DC, Johnson BE 1993 Atrial natriuretic factor and arginine vasopressin production in tumor cell lines from patients with lung cancer and their relationship to serum sodium. Cancer Res 53:67-74
92. Woll PJ, Rozengurt E 1989 Multiple neuropeptides mobilize calcium in small cell lung cancer: effects of vasopressin, bradykinin, cholecystokinin, galanin and neurotensin. Biochem Biophys Res Commun 164:66-73
93. Davis TP, Crowell S, Mclnturff B, Louis R, Gillespie T 1991 Neurotensin may function as a regulatory peptide in small cell lung cancer. Peptides 12:17-23
94. Hong M, Moody TW 1991 Vasopressin elevates cytosolic calcium in small cell lung cancer cells. Peptides 12:1315-1319
95. 2+ mobilization, inositol phosphate accumulation, and clonal growth in small cell lung cancer cells. Cancer Res 51:1674-1679
96. 2+ mobilization and clonal growth in small cell lung cancer cells. Cancer Res 52: 6031-6035
97. Bunn Jr PA, Chan D, Dienhart DG, Tolley R, Tagawa M, Jewett PB 1992 Neuropeptide signal transduction in lung cancer: clinical implications of bradykinin sensitivity and overall heterogeneity. Cancer Res 52:24-31
98. Battey JF, Way JM, Corjay MH, Shapira H, Kusano K, Harkins R, Wu JM, Stattery T, Mann E, Feldman RI1991 Molecular cloning of the bombesin/gastrin-releasing peptide receptor from Swiss 3T3 cells. Proc Natl Acad Sci USA 88:395-399
99. Morel A, O’Carroll A-M, Brownstein MJ, Lolait SJ 1992 Molecular cloning and expression of a rat Via arginine vasopressin receptor. Nature 356:523-526
100. Kopin AS, Lee Y-M, McBride EW, Miller LJ, Lu M, Lin HY, Kolakowski Jr LF, Beinbom M 1992 Expression cloning and characterization of the canine parietal cell gastrin receptor. Proc Natl Acad Sci USA 89:3605-3609
101. Wank SA, Pisegna JR, de Weerth A 1992 Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression. Proc Natl Acad Sci USA 89:8691-8695
102. Lee Y-M, Beinbom M, McBride EW, Lu M, Kolakowski Jr LF, Kopin AS 1993 The human brain cholecystokinin-B/gastrin receptor: cloning and characterization. J Biol Chem 268:8164-8169
103. Trepel JB, Moyer JD, Heikkila R, Sausville EA 1988 Modulation of bombesin-induced phosphatidylinositol hydrolysis in a smallcell lung-cancer cell line. Biochem J 255:403-410
104. Sharoni Y, Viallet J, Trepel JB, Sausville ED 1990 Effect of guanine and adenine nucleotides on bombesin-stimulated phospholipase C activity in membranes from Swiss 3T3 and small cell lung carcinoma cells. Cancer Res 50:5257-5262
105. Baxter G, Oto E, Daniel-Issakani S, Strulovici B 1992 Constitutive presence of a catalytic fragment of protein kinase Ce in a small cell lung carcinoma cell line. J Biol Chem 267:1910-1917
106. Johnson GL, Dhanasekaran N 1989 The G-protein family and their interaction with receptors. Endocr Rev 10:317-331
107. Viallet J, Sharoni Y, Frucht H, Jensen RT, Minna JD, Sausville EA 1990 Cholera toxin inhibits signal transduction by several mitogens and the in vitro growth of human small-cell lung cancer. J Clin Invest 86:1904-1912
108. Wall PJ, Rozengurt E 1990 A neuropeptide antagonist that inhibits the growth of small cell lung cancer in vitro. Cancer Res 50:3968-3973
109. Aguayo SA 1993 Pulmonary neuroendocrine cells in tobacco-related lung disorders. Anat Rec 236:122-127
110. Tahara E 1990 Growth factors and oncogenes in human gastrointestinal carcinomas. J Cancer Res Clin Oncol 116:121-131
111. Sundler F, Ekblad E, Hakanson R 1991 The neuroendocrine system of the gut—an update. Acta Oncol 30:419-427
112. Nakata H, Matsui T, Ito M, Tamiguchi T, Naribayashi Y, Arima N, Nakamura A, Kinoshita Y, Chihara K, Hosoda S, Chiba J 1992 Cloning and characterization of gastrin receptor from ECL carcinoid tumor oiMastomys natalensis. Biochem Biophys Res Commun 187:1151-1157
113. Preston SR, Woodhouse LF, Jones-Blackett S, Wyatt JI, Primrose JN 1993 High affinity binding sites for gastrin releasing peptide on human gastric cancer and menetrien’s mucosa. Cancer Res 53: 5090-5092
114. Sobhani I, Lehy T, Laurent-Puig P, Cadiot G, Ruszniewski P, Mignon M 1993 Chronic endogenous hypergastrinemia in humans: evidence for a mitogenic effect on the colonic mucosa. Gastroenterology 105:22-30
115. Seitz J-F, Giovannini M, Gouvemet J, Gautheir AP 1991 Elevated serum gastrin levels in patients with colorectal neoplasia. J Clin Gastroenterol 13:1541-1545
116. Narayan S, Guo Y-S, Townsend Jr CM, Singh P 1990 Specific binding and growth effects of bombesin-related peptides on mouse colon cancer cells in vitro. Cancer Res 50:6772-6798
117. Frucht H, Gazdar AF, Park J-A, Oie H, Jensen RT 1992 Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells. Cancer Res 52:1114-1122
118. Baldwin GS, Zhang Q-X 1992 Measurement of gastrin and transforming growth factor a messenger RNA levels in colonic carcinoma cell lines by quantitative polymerase chain reaction. Cancer Res 52:2262-2267
119. Radolovic S, Miller G, Schally AV 1991 Inhibition of growth of HT-29 human colon cancer xenografts in nude mice by treatment with bombesin/gastrin releasing peptide antagonist (RC-3095). Cancer Res 51:6006-6009
120. Hoosein NM, Kienes PA, Curry RC, Rovati CC, McGilbra DK, Brattain MG 1988 Anti-proliferative effects of gastrin receptor antagonists and antibodies to gastrin on human colon carcinoma cell lines. Cancer Res 48:7179-7183
121. Sunday ME, Wolfe HJ, Roos BA, Chin WW, Spindel ER 1988 Gastrin-releasing peptide gene expression in developing, hyperplastic, and neoplastic human thyroid C-cells. Endocrinology 122: 1551-1558
122. Rehfeld JF, Johnson AH, Odum L, Bardram L, Schifter S, Scopsi L 1990 Non-sulfated cholecystokinin in human medullary thyroid carcinomas. J Endocrinology 124:501-506
123. Burton PJ, Moniz C, Knight DE 1990 Parathyroid hormone related peptide can function as an autocrine growth factor in human renal cell carcinoma. Biochem Biophys Res Commun 167:1134-1138